Karyopharm Therapeutics Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
Karyopharm Therapeutics Inc. (KPTI) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$192.38 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-02-13
- Karyopharm Therapeutics Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$192.38M.
- Karyopharm Therapeutics Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$76.44M.
- Karyopharm Therapeutics Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$143.02M.
- Karyopharm Therapeutics Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$165.81M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$192.38M 10-K · filed 2026-02-13 |
| 2024-12-31 | -$76.44M 10-K · filed 2026-02-13 |
| 2023-12-31 | -$143.02M 10-K · filed 2026-02-13 |
| 2022-12-31 | -$165.81M 10-K · filed 2025-02-19 |
| 2021-12-31 | -$93.77M 10-K · filed 2024-02-29 |
| 2020-12-31 | -$158.88M 10-K · filed 2023-02-17 |
| 2019-12-31 | -$176.20M 10-K · filed 2022-03-01 |
| 2018-12-31 | -$149.69M 10-K · filed 2021-02-24 |
| 2017-12-31 | -$93.24M 10-K · filed 2020-02-26 |
| 2016-12-31 | -$82.51M 10-K · filed 2019-02-28 |
| 2015-12-31 | -$96.68M 10-K · filed 2018-03-15 |
| 2014-12-31 | -$72.89M 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |